Whereas GBM-infiltrating microglia are characterized by upregulating MHC II-associated molecules when compared to control individuals whose expression might be influenced by patient sex [17,102], the presence of these antigen-presenting molecules might determine responses to anti-PD-1 therapy in recurrent GBM patients [101,103]. This evidence concerns the gene PDCD1 and glioblastoma.